BGM Group Ltd
BGM
View Detailed Chart
9.990USD
-0.450-4.31%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
981.96MMarket Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-4.31%
5 Days
+37.23%
1 Month
+31.97%
6 Months
-2.44%
Year to Date
+18.22%
1 Year
+23.95%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-17Key Insights
Its valuation is considered undervalued,and institutional recognition is very high. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Growing
The company is in a growing phase, with the latest annual income totaling USD 25.10M.
Fairly Valued
The company’s latest PE is -36.65, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 114.93M shares, increasing 26.84% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 29.97K shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Ticker SymbolBGM
CompanyBGM Group Ltd
CEOMr. Zhanchang Xin
Websitehttps://www.bgmgroupltd.com/
Related Instruments
+0.37%
-1.73%
+0.54%
-0.80%
-0.14%
+6.29%
+0.49%
+0.41%
+1.21%
+0.35%
+1.51%
-0.01%
-1.26%
-0.31%
-0.17%
-1.49%
-0.03%
+0.11%
+2.26%
+0.10%
